Overview
Alternative Name Lidocaine N-ethyl chloride
Lyophilized Powder yes
Source Synthetic
MW: 298.85
Purity: >99% (HPLC)
Effective concentration 1-50 mM.
Structure
Chemical name N-(2,6-Dimethylphenylcarbamoylmethyl) triethylammonium chloride.
Molecular formula C16H27N2OCl.
CAS No.: 5369-03-9
Activity QX-314 chloride is an intracellular blocker of NaV channels1-4.
References-Activity
- Llinas, R. and Yarom, Y. (1981) J. Physiol. 315, 549.
- Congar, P. et al. (1995) J. Neurophysiol. 73, 421.
- Li, D.P. et al. (2005) J. Neurophysiol. 93, 393.
- Koike-Tani, M. (2005) J. Neurosci. 25, 199.
Shipping and storage Shipped at room temperature. Product as supplied can be stored intact at room temperature for four years.
Solubility Water. Centrifuge all product preparations before use (10000 x g 5 min).
Storage of solutions Up to two weeks at 4°C or six months at -20°C.
Protect from light. Hygroscopic.
Protect from light. Hygroscopic.
Our bioassay
Alomone Labs QX-314 chloride inhibits native NaV1.5 currents expressed in Xenopus oocytes.Dose-response of QX-314 chloride (#Q-150) inhibition on inward Na+ currents. Using two electrode voltage clamps, membrane potential was held at -100 mV and currents were elicited by 25 ms depolarization to -20 mV, delivered every 5 sec. Left: Dose-response curve for one experiment. Right: Traces before (red) and during bath application of different concentrations of QX-314 chloride.
References - Scientific background
- Sunami, A. et al. (2000) Proc. Natl. Acad. Sci. U.S.A. 97, 2326.
- Llinas, R. and Yarom, Y. (1981) J. Physiol. 315, 549.
- Congar, P. et al. (1995) J. Neurophysiol. 73, 421.
- Li, D.P. et al. (2005) J. Neurophysiol. 93, 393.
- Koike-Tani, M. (2005) J. Neurosci. 25, 199.
Scientific background This local anesthetic is a blocker of voltage-dependent Na+ channels. QX-314 blocks all NaV channels once exposed to the intracellular face of the channel protein. However, this compound can penetrate the cell interior once applied outside the cell. Via certain types of NaV channels, it can permeate and exert blocking activity via TTX-sensitive channels.1 Intracellular recordings from inferior olivary neurons in brain stem slice preparations demonstrated that Na+-dependent action potentials were completely blocked for approximately five minutes after impalement with a microelectrode containing 50 mM QX-314, whereas the low-threshold Ca2+ spike was still generated.2 QX-314 is widely used to block NaV channels and used as a tool in neurophysiological recordings.2-5
Target Various NaV Na+ channels
Lyophilized Powder
QX-314 chloride (#Q-150) is a highly pure, synthetic, and biologically active compound.
For research purposes only, not for human use
Last Update: 07/05/2024
Applications
Citations
Citations
Powered by BiozProduct citations
- Ambroziak, W. et al. (2018) Hippocampus 28, 707.
- Tang, Y. et al. (2018) Eur. J. Neurosci. 47, 866.
- Butola, T. et al. (2017) Front. Synaptic Neurosci. 9, 14.
- Dickie, A.C. et al. (2017) J. Neurosci. 37, 6488.
- Irie, T. and Trussell, L.O. (2017) Neuron 96, 856.
- Ransom, C.B. et al. (2017) Neurochem. Res. 42, 2551.
- Beckley, J.T. et al. (2016) J. Neurosci. 36, 701.
- Scheuss, V. and Bonhoeffer, T. (2014) Cereb. Cortex 24, 3142.
- Gunn, B.G. et al. (2013) J. Neurosci. 33, 19534.
- Khelfaoui, M. et al. (2013) Philos. Trans. R. Soc. Lond. B. Biol. Sci. 369, 20130160.
- Quattrocolo, G. and Maccaferri, G. (2013) J. Neurosci. 33, 5486.
- Ransom, C.B. et al. (2013) J. Neurophysiol. 109, 803.
- Suvrathan, A. et al. (2013) Philos. Trans. R. Soc. Lond. B. Biol. Sci. 369, 20130151.
- Tao, W. et al. (2013) J. Neurosci. 33, 3738.
- Armogida, M. et al. (2010) Synapse 64, 161.
- Marchionni, I. et al. (2010) J. Physiol. 588, 2859.
- Rinke, I. et al. (2010) J. Neurosci. 30, 4776.
- Wrobel, L.J. et al. (2010) Neuroscience 165, 723.
- Zhan, R.Z. et al. (2010) J. Neurophysiol. 104, 3293.
- Hermann, J. et al. (2009) J. Neurophysiol. 101, 20.
- Kuo, S.P. et al. (2009) J. Neurosci. 29, 9625.
- Pilpel, Y. et al. (2009) J. Physiol. 587, 787.
- Watanabe, K. et al. (2009) J. Neurophysiol. 101, 665.
- Graciotti, L. et al. (2008) Neuromuscul. Disord. 18, 220.
- Koike-Tani, M. et al. (2008) J. Physiol. 586, 2263.
- Olijslagers, J.E. et al. (2008) Eur. J. Neurosci. 27, 2542.
- Vikman, K.S. et al. (2008) J. Physiol. 586, 515.
- Abrahamsson, T. et al. (2007) J. Neurophysiol. 98, 2604.
- Fujiwara-Tsukamoto, Y. et al. (2007) Eur. J. Neurosci. 25, 2713.
- Lu, T. and Trussell, L.O. (2007) J. Neurosci. 27, 808.
- Singhal, S.K. et al. (2007) Neuropharmacology 52, 387.
- Zhang, H.M. et al. (2007) J. Neurophysiol. 97, 102.
- Akerman, C.J. and Cline, H.T. (2006) J. Neurosci. 26, 5117.
- Boddy, G. et al. (2006) Can. J. Physiol. Pharmacol. 84, 589.
- Hige, T. et al. (2006) Eur. J. Neurosci. 24, 1955.
- Nuriya, M. et al. (2006) Proc. Natl. Acad. Sci. U. S. A. 103, 786.
- Panatier, A. et al. (2006) J. Physiol. 573, 711.
- Tu, B. et al. (2006) Neuroscience 143, 1085.
- Abrahamsson, T. et al. (2005) J. Physiol. 569, 737.
- Bhaukaurally, K. et al. (2005) Eur. J. Neurosci. 21, 2459.
- Ishikawa, T. et al. (2005) J. Physiol. 568, 199.
- Karst, H. and Joëls, M. (2005) J. Neurophysiol. 94, 3479.
- Karst, H. et al. (2005) Proc. Natl. Acad. Sci. U. S. A. 102, 19204.
- Koike-Tani, M. et al. (2005) J. Neurosci. 25, 199.
- Bailey, S.J. et al. (2004) Neuropharmacology 46, 31.
- Bengtson, C.P. et al. (2004) J. Physiol. 555, 323.
- Maggi, L. et al. (2004) J. Physiol. 559, 863.
- Panatier, A. et al. (2004) Neuropharmacology 47, 333.
- Sasaki, K. et al. (2004) Mol. Pharmacol. 66, 330.
- Azdad, K. et al. (2003) J. Neurophysiol. 90, 559.
- Feng, L. et al. (2003) J. Neurosci. 23, 5381.
- Ferri, C.C. and Ferguson, A.V. (2003) J. Neuroendocrinol. 15, 126.
- Fujiwara-Tsukamoto, Y. et al. (2003) Neuroscience 119, 265.
- Karst, H. and Joëls, M. (2003) J. Neurophysiol. 89, 625.
- Ogier, R. and Raggenbass, M. (2003) Eur. J. Neurosci. 17, 2639.
- Piet, R. et al. (2003) Eur. J. Neurosci. 17, 1777.
- Strege, P.R. et al. (2003) Am. J. Physiol. Gastrointest. Liver Physiol. 285, G1111.
- Marchetti, C. et al. (2002) Eur. J. Neurosci. 15, 975.
- Mori, M. and Gerber, U. (2002) J. Physiol. 544, 793.
- Mori, M. et al. (2002) J. Physiol. 539, 191.
- Lupica, C.R. et al. (2001) J. Neurophysiol. 86, 261.
- Mannaioni, G. et al. (2001) J. Neurosci. 21, 5925.
- Molnár, P. and Nadler, J.V. (2001) J. Neurophysiol. 85, 1932.
- Mori, M. et al. (2001) J. Physiol. 535, 115.
- Carlson, G.C. et al. (2000) J. Neurosci. 20, 2011.
- Guatteo, E. et al. (2000) J. Neurosci. 20, 6013.
- Jensen, K. et al. (2000) Brain Res. 880, 198.
- Molnár, P. and Nadler J.V. (2000) Eur. J. Pharmacol. 391, 255.
- Zaninetti, M. and Raggenbass, M. (2000) Eur. J. Neurosci. 12, 3975.
